A Novel One-Pot, Two-Step Reaction for the Synthesis of Indenopyrrolo[3,2-c]pyridinone Derivatives with a Recyclable Catalyst

Chunmei Li; Furen Zhang; Chenze Qi

doi:10.1055/s-0037-1609655

Synlett, Table of Contents

Synlett 2018; 29(20): 2707-2711
DOI: 10.1055/s-0037-1609655

letter

A Novel One-Pot, Two-Step Reaction for the Synthesis of Indenopyrrolo[3,2-c]pyridinone Derivatives with a Recyclable Catalyst

Chunmei Li

,

Furen Zhang*

School of Chemistry and Chemical Engineering, Zhejiang Key Laboratory of Alternative Technologies for Fine Chemicals Process, Shaoxing University, Shaoxing, Zhejiang Province 312000, P. R. of China Email: frzhang@usx.edu.cn

,

Chenze Qi

› Author Affiliations

Abstract

All articles of this category

Abstract

An efficient strategy was developed for the synthesis of indenopyrrolopyridinone derivatives from 4-hydroxy-6-methyl-2H-pyran-2-one, an amine, and 2,2-dihydroxy-1H-indene-1,3(2H)-dione by a one-pot, two-step, four-component process. The one-pot reaction gives various substituted indenopyrrolopyridinones in good yields and uses a solid acid as a recyclable catalyst in water. This procedure has the advantages of inexpensive substrates, a reusable solid-supported catalyst, and a convenient one-pot operation.

Key words

multicomponent reaction - one-pot reaction - hydroxymethylpyranonone - amines - dihydroxyindenedione - indenopyrrolopyridinones

Full Text

References

References and Notes

1a Shah S, Lee C, Choi H, Gautam J, Jang H, Kim GJ, Lee Y.-J, Chaudhary CL, Park SW, Nam T.-G, Kim J.-A, Jeong B.-S. Org. Biomol. Chem. 2016; 14: 4829
1b Zhang J, Shen W, Li X, Chai Y, Li S, Lv K, Guo H, Liu M. Molecules 2016; 21: 1674
1c Wang M, Ye C, Liu M, Wu Z, Li L, Wang C, Liu X, Guo H. Bioorg. Med. Chem. Lett. 2015; 25: 2782
1d Chu W, Zhou D, Gaba V, Liu J, Li S, Peng X, Xu J, Dhavale D, Bagchi DP, Avignon A, Shakerdge NB, Bacskai BJ, Tu Z, Kotzbauer PT, Mach RH. J. Med. Chem. 2015; 58: 6002
1e Chen G, Weng Q, Fu L, Wang Z, Yu P, Liu Z, Li X, Zhang H, Liang G. Bioorg. Med. Chem. 2014; 22: 6953
1f Yamagishi H, Shirakami S, Nakajima Y, Tanaka A, Takahashi F, Hamaguchi H, Hatanaka K, Moritomo A, Inami M, Higashi Y, Inoue T. Bioorg. Med. Chem. 2015; 23: 4846

2 Combs AP, Maduskuie TP. J, Falahatpisheh N. US 2015307493, 2015
3 Menichincheri M, Bargiotti A, Berthelsen J, Bertrand JA, Bossi R, Ciavolella A, Cirla A, Cristiani C, Croci V, D'Alessio R, Fasolini M, Fiorentini F, Forte B, Isacchi A, Martina K, Molinari A, Montagnoli A, Orsini P, Orzi F, Pesenti E, Pezzetta D, Pillan A, Poggesi I, Roletto F, Scolaro A, Tato M, Tibolla M, Valsasina B, Varasi M, Volpi D, Santocanale C, Vanotti E. J. Med. Chem. 2009; 52: 293
4 Adler M, Burdick DJ, Crawford T, Duplessis M, Magnuson S, Nasveschuk CG, Romero FA, Tang Y, Tsui VH.-W, Wang S. US 2018009805, 2018
5 Smith RA, Fathi Z, Brown S.-E, Choi S, Fan J, Jenkins S, Kluender HC. E, Konkar A, Lavoie R, Mays R, Natoli J, O'Connor SJ, Ortiz AA, Podlogar B, Taing C, Tomlinson S, Tritto T, Zhang Z. Bioorg. Med. Chem. Lett. 2007; 17: 673

6a Davis T, Rokicki MJ, Bagley MC, Kipling D. Chem. Cent. J. 2013; 7: 18
6b Caruso M, Valsasina B, Ballinari D, Bertrand J, Brasca MG, Caldarelli M, Cappella P, Fiorentini F, Gianellini LM, Scolaro A, Beria I. Bioorg. Med. Chem. Lett. 2012; 22: 96
6c Vanotti EA, Bargiotti RA, Berthelsen J, Bosotti R, Ciavolella A, Cirla A, Cristiani C, D’Alessio R, Forte B, Isacchi A, Martina K, Menichincheri M, Molinari A, Montagnoli A, Orsini P, Pillan A, Roletto F, Scolaro A, Tibolla M, Valsasina B, Varasi M, Volpi D, Santocanale C. J. Med. Chem. 2008; 51: 487

7a Croix C, Massip S, Viaud-Massuard M.-C. Chem. Commun. 2018; 54: 5538
7b Zhang Z, Gao X, Wan Y, Huang Y, Huang G, Zhang G. ACS Omega 2017; 2: 6844
7c Li Y, Lin Z. Organometallics 2015; 34: 3538
7d Li Z, Kumar A, Sharma SK, Parmar VS, Van der Eycken EV. Tetrahedron 2015; 71: 3333
7e Deguest G, Devineau A, Bischoff L, Fruit C, Marsais F. Org. Lett. 2006; 8: 5889

8a Tierney MT, Grinstaff MW. J. Org. Chem. 2000; 65: 5355
8b Rochais C, Dallemagne P, Rault S. Anti-Cancer Agents Med. Chem. 2009; 9: 369
8c Diana P, Stagno A, Barraja P, Montalbano A, Carbone A, Parrino B, Cirrincione G. Tetrahedron 2011; 67: 3374
8d Hemmerling H.-J, Reiss G. Synthesis 2009; 985

9 Brown DW, Graupner PR, Sainsbury M, Shertzer HG. Tetrahedron 1991; 47: 4383
10 Butera JA, Antane SA, Hirth B, Lennox JR, Sheldon JH, Norton NW, Warga D, Argentieri TM. Bioorg. Med. Chem. Lett. 2001; 11: 2093
11 Bal C, Baldeyrou B, Moz F, Lansiaux A, Colson P, Kraus-Berthier L, Léonce S, Pierre A, Boussard M.-F, Rousseau A, Wierzbicki M, Bailly C. Biochem. Pharmacol. 2004; 68: 1911

12a Wang S, Yang Q, Dong J, Li C, Sun L, Song C, Chang J. Eur. J. Org. Chem. 2013; 7631
12b Chang J, Sun L, Dong J, Shen Z, Zhang Y, Wu J, Wang R, Wang J, Song C. Synlett. 2012; 23: 2704
12c Lobo G, Monasterios M, Rodrigues J, Gamboa N, Capparelli MV, Martínez-Cuevas J, Lein M, Jung K, Abramjuk C, Charris J. Eur. J. Med. Chem. 2015; 96: 281
12d Pathak S, Das D, Kundu A, Maity S, Guchhait N, Pramanik A. RSC Adv. 2015; 5: 17308
12e Jiang B, Wang X, Xu H.-W, Tu M.-S, Tu S.-J, Li G. Org. Lett. 2013; 15: 1540

13 Vekariya RH, Patel KD, Patel HD. RSC Adv. 2015; 5: 90819

14a Vekariya RH, Prajapati NP, Patel HD. Synth. Commun. 2016; 46: 1713
14b Ziarani GM, Lashgari N, Badiei A. J. Mol. Catal. A: Chem. 2015; 397: 166
14c Gholamzadeh P, Ziarani GM, Lashgari N, Badiei A. J. Mol. Catal. A: Chem. 2014; 391: 208
14d Vekariya RH, Patel HD. ARKIVOC 2015; (i): 136

15a Li C, Liang X, Zhang F, Qi C. Catal. Commun. 2015; 62: 6
15b Chen Z, Shi Y, Shen Q, Xu H, Zhang F. Tetrahedron Lett. 2015; 56: 4749
15c Zhang F, Li C, Liang X. Green Chem. 2018; 20: 2057

16a Kraus GA, Wanninayake UK, Bottoms J. Tetrahedron Lett. 2016; 57: 1293
16b Dong Y, Nakagawa-Goto K, Lai C.-Y, Morris-Natschke SL, Bastow KF, Lee K.-H. Bioorg. Med. Chem. Lett. 2011; 21: 2341
16c Weng Y, Zhou H, Sun C, Xie Y, Su W. J. Org. Chem. 2017; 82: 9047
16d Balalas T, Abdul-Sada A, Hadjipavlou-Litina DJ, Litinas KE. Synthesis 2017; 49: 2575

17 2,5-Disubstituted 5a,10a-Dihydroxy-3-methyl-2,5,5a,10a-tetrahydroindeno[2′,1′:4,5]pyrrolo[3,2-c]pyridine-1,10-diones 5a–l; General Method A mixture of pyranone 1 (0.5 mmol), the appropriate amine 2 (1.0 mmol), and solid acid (10 mg) in H₂O (3.0 mL) in sealed tube was heated at 80 °C until starting material was completely converted (~2 h; TLC). Indenedione 4 (0.5 mmol) was then added and the mixture was heated at 80 °C for another 4 h. The mixture was cooled to r.t. and the solid product was collected by filtration and washed with H₂O. The crude product and solid acid were treated with hot 95% EtOH. The catalyst was removed by filtration, and the pure product 5 was obtained from the mother liquor. 5a,10a-Dihydroxy-3-methyl-2,5-diphenyl-2,5,5a,10a-tetrahydroindeno[2′,1′:4,5]pyrrolo[3,2-c]pyridine-1,10-dione (5a) Yellow crystals; yield: 177.0 mg (81%); mp 238–240 °C. IR (KBr): 3403, 1721, 1638, 1487, 1454, 1357, 1197, 1021, 943, 870, 772 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 7.85–7.86 (m, 1 H, ArH), 7.39–7.52 (m, 10 H, ArH), 7.20–7.23 (m, 1 H, ArH), 7.11–7.14 (m, 1 H, ArH), 6.78 (dd, J = 5.6, 2.8 Hz, 1 H, ArH), 6.41 (br s, 1 H, OH), 5.63 (s, 1 H, CH), 5.36 (s, 1 H, OH), 1.83 (s, 3 H, CH₃). ¹³C NMR (100 MHz, CDCl₃): δ = 197.3, 161.2, 155.9, 150.7, 147.7, 138.3 (2 C), 136.9, 135.2 (2 C), 135.0, 129.9, 129.4, 128.8, 128.7, 128.5, 128.4, 127.8 (2 C), 124.9, 124.5, 100.2, 96.2, 93.4, 82.7, 77.3, 22.5. HRMS (ESI): m/z [M + H]⁺ calcd for C₂₇H₂₁N₂O₄ ⁺: 437.1496; found: 437.1495.
18 5-Aryl-5a,10a-dihydroxy-3-methyl-5a,10a-dihydro-1H-indeno[1,2-b] pyrano[3,4-d]pyrrole-1,10(5H)-diones 7a–d; General Procedure A mixture of pyranone 1 (0.5 mmol), the appropriate amine 2 (0.5 mmol), and solid acid (10 mg) in water (3.0 mL) in a sealed tube was stirred at r.t. until the starting material was completely converted (~12 h; TLC). Indenedione 4 (0.5 mmol) was then added and the mixture was heated at 80 °C for another 4 h. The mixture was cooled to r.t. and the solid product was collected by filtration and washed with H₂O. The crude product and the solid acid were treated with hot 95% EtOH and water. The catalyst was removed by filtration, and the pure product 7 was obtained from the mother liquor. 5a,10a-Dihydroxy-5-(4-methoxyphenyl)-3-methyl-5a,10a-dihydro-1H-indeno[1,2-b]pyrano[3,4-d]pyrrole-1,10(5H)-dione (7a) Gray solid; yield: 147.2 mg (75%); mp 286–288 °C. IR (KBr): 3401, 1720, 1637, 1488, 1451, 1356, 1149, 1028, 875, 758 cm^–1. ¹H NMR (400 MHz, DMSO-d₆ ): δ = 7.60 (d, J = 7.2 Hz, 1 H, ArH), 7.53–7.63 (m, 2 H, ArH), 7.38 (s, 1 H, OH), 7.20 (d, J = 8.0 Hz, 2 H, ArH), 7.07 (d, J = 8.8 Hz, 2 H, ArH), 6.73 (d, J = 7.6 Hz, 1 H, ArH), 6.36 (s, 1 H, OH), 5.59 (s, 1 H, CH), 3.83 (s, 3 H, OMe), 2.06 (s, 3 H, CH₃). ¹³C NMR (100 MHz, DMSO-d₆ ): δ = 197.4, 167.4, 159.4, 158.5, 158.2, 147.7, 135.7 (2 C), 135.0, 130.8, 128.4 (2 C), 125.6 (2 C), 123.8, 114.9, 97.1, 93.1, 91.4, 83.1, 55.8, 20.4. HRMS (ESI): m/z [M + H]⁺ calcd for C₂₂H₁₈NO₆ ⁺: 392.1129; found: 392.1131

Supplementary Material

Supporting Information